- Your selection
- Clear all
- Medical Devices x
18 cases found.
mySugr is a mobile health startup which allows us to explore several interlinked trends. One trend is the proliferation of health related applications, and an understanding of factors which seem to be related to success in the digital health space.
- By
Reference 6204
Published 22 Apr 2016
Topic Entrepreneurship
Region Global
Industry Medical Devices
mySugr is a mobile health startup which allows us to explore several interlinked trends. One trend is the proliferation of health related applications, and an understanding of factors which seem to be related to success in the digital health space.
Mindray Medical International Limited, China's second largest medical device manufacturer, had global sales of 2.23 billion RMB in 2007. Since 2002, it had launched between seven and nine new products every year across four product lines: Patient Monitoring & Life Support products, the In-Vitro Diagnostic Products, Medical Imaging Systems and Veterinary.
- By
Reference 6023
Published 24 Feb 2014
Topic Marketing
Region Global
Industry Medical Devices
Mindray Medical International Limited, China's second largest medical device manufacturer, had global sales of 2.23 billion RMB in 2007. Since 2002, it had launched between seven and nine new products every year across four product lines: Patient Monitoring & Life Support products, the In-Vitro Diagnostic Products, Medical Imaging Systems and Veterinary.
Executives in heavily regulated industries, such as Healthcare, often feel their hands are tied by rules and regulations which some claim to even interfere with their ability to innovate. As such, it is not uncommon to find regulated firms competing in the same way for decades without ever challenging the status quo.
- By
Reference 6013
Published 20 Dec 2013
Topic Strategy
Region Europe
Industry Medical Devices
Executives in heavily regulated industries, such as Healthcare, often feel their hands are tied by rules and regulations which some claim to even interfere with their ability to innovate. As such, it is not uncommon to find regulated firms competing in the same way for decades without ever challenging the status quo.
The case "Rehability (B)" illustrates how one firm created a blue ocean of new market space in the highly regulated and competitive German healthcare industry in the early 1990s.
- By
Reference 6013
Published 20 Dec 2013
Topic Strategy
Region Europe
Industry Medical Devices
The case "Rehability (B)" illustrates how one firm created a blue ocean of new market space in the highly regulated and competitive German healthcare industry in the early 1990s.
This case investigates how Philips became a globally integrated enterprise - how it “de-risked” its business and internationalized its supply chain (moving most production from Europe to Asia). The objective is to highlight the factors and analysis involved in “location cost economics.” (The case is developed around the leadership of INSEAD alumna and board member Barbara Kux.)
- By
Reference 5859
Published 27 Feb 2012
Topic Strategy
Region Asia
Industry Electrical/Electronic Manufacturing, Medical Devices
This case investigates how Philips became a globally integrated enterprise - how it “de-risked” its business and internationalized its supply chain (moving most production from Europe to Asia). The objective is to highlight the factors and analysis involved in “location cost economics.” (The case is developed around the leadership of INSEAD alumna and board member Barbara Kux.)
The (A) case describes how GE Healthcare developed an ECG device optimized for low-income mass markets in India. It also discusses the organizational changes GE made to better serve the Bottom of Pyramid (BOP) markets.
- By
Reference 5776
Published 29 Mar 2011
Topic Strategy
Region Asia
Industry Medical Devices, Consumer Electronics
The (A) case describes how GE Healthcare developed an ECG device optimized for low-income mass markets in India. It also discusses the organizational changes GE made to better serve the Bottom of Pyramid (BOP) markets.
The (B) case discusses an ethical dilemma in selling compact ultrasound devices in BOP markets.
- By
Reference 5776
Published 29 Mar 2011
Topic Strategy
Region Asia
Industry Medical Devices, Consumer Electronics
The (B) case discusses an ethical dilemma in selling compact ultrasound devices in BOP markets.
Lucentis, a forthcoming breakthrough drug against wet age-related macular degeneration (AMD), will be marketed by Genentech in the U.S. and Novartis in other countries.
- By
Reference 5718
Published 27 Jan 2014
Topic Marketing
Region Global
Industry Pharmaceuticals, Medical Devices
Lucentis, a forthcoming breakthrough drug against wet age-related macular degeneration (AMD), will be marketed by Genentech in the U.S. and Novartis in other countries.
Female Health Company produces the female condom which is distributed by non-profit organisations in Africa to prevent HIV/AIDS. In February 2009 the company has to decide whether to buy back stock. This provides an opportunity to check whether the firm is fairly valued and whether it should reconsider its capital structure and payout policy.
- By
Reference 5717
Published 26 May 2015
Topic Economics & Finance
Region Other Regions
Industry Medical Devices
Female Health Company produces the female condom which is distributed by non-profit organisations in Africa to prevent HIV/AIDS. In February 2009 the company has to decide whether to buy back stock. This provides an opportunity to check whether the firm is fairly valued and whether it should reconsider its capital structure and payout policy.
The main case describes the design, implementation and operational implementation of a focused clinic in the Middle East. The ICLDC provides team-based care for managing diabetes with clear processes that have benefitted from lean Six Sigma tools. A supplement describes how the ICLDC fits into the broader context of the rapidly changing health system in the United Arab Emirates.
- By
Reference 5676
Published 25 Mar 2010
Topic Operations
Region Middle-East
Industry Medical Devices
The main case describes the design, implementation and operational implementation of a focused clinic in the Middle East. The ICLDC provides team-based care for managing diabetes with clear processes that have benefitted from lean Six Sigma tools. A supplement describes how the ICLDC fits into the broader context of the rapidly changing health system in the United Arab Emirates.
The main case describes the design, implementation and operational implementation of a focused clinic in the Middle East. The ICLDC provides team-based care for managing diabetes with clear processes that have benefitted from lean Six Sigma tools. A supplement describes how the ICLDC fits into the broader context of the rapidly changing health system in the United Arab Emirates.
- By
Reference 5676
Published 25 Mar 2010
Topic Operations
Region Middle-East
Industry Medical Devices
The main case describes the design, implementation and operational implementation of a focused clinic in the Middle East. The ICLDC provides team-based care for managing diabetes with clear processes that have benefitted from lean Six Sigma tools. A supplement describes how the ICLDC fits into the broader context of the rapidly changing health system in the United Arab Emirates.
DeepBreeze illustrates the challenging voyage of many startups in the medical device sector as it navigates clinical trials, regulatory agencies and reimbursement issues in a quest for growth. While it perseveres in assessing the value that patients, providers and purchasers obtain from the product, DeepBreeze is exhausting its funds and still looking for a commercial breakthrough.
- By
Reference 5620
Published 30 Nov 2009
Topic Operations
Region Global
Industry Medical Devices
DeepBreeze illustrates the challenging voyage of many startups in the medical device sector as it navigates clinical trials, regulatory agencies and reimbursement issues in a quest for growth. While it perseveres in assessing the value that patients, providers and purchasers obtain from the product, DeepBreeze is exhausting its funds and still looking for a commercial breakthrough.